Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes

Biomedical Research

Volumn 31, Issue 5, 2010, Pages 281-286

  Hozumi, Akira ^a   Osaki, Makoto ^a   Sakamoto, Kazutaka ^a   Goto, Hisataka ^a   Fukushima, Tatsuya ^a   Baba, Hideo ^a   Shindo, Hiroyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; DEXAMETHASONE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; PHOTOMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADIPOCYTES; ADIPONECTIN; BONE MARROW CELLS; CELLS, CULTURED; DEXAMETHASONE; FEMUR HEAD NECROSIS; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78249287854     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.31.281     Document Type: Article

References (22)

1. Alessi MC, Poggi M and Juhan-Vague I (2007) Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 18, 240-245.
2. Cooper MS (2004) Sensitivity of bone to glucocorticoids. Clin Sci 107,111-123.
3. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M and Stewart PM (2000) Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. Bone 27, 375-381.
4. Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D and Marti HP (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74, 1147-1152.
5. Fukui K, Kominami R, Shinohara H and Matsumoto T (2006) Glucocorticoid induces micro-fat embolism in the rabbit: a scanning electron microscopic study. J Orthop Res 24, 675-683.
6. Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T and Wang P (1999) The plasminogen activator inhibitor-1 gene, hypoibrinolysis, and osteonecrosis. Clin Orthop Relat Res 133-146.
7. Hozumi A, Osaki M, Goto H, Sakamoto K, Inokuchi S and Shindo H (2009) Bone marrow adipocytes support dexamethazsone-induced osteoclast differentiation. Biochem Biophys Res Commun 382,780-784.
8. Halleux CM, Servais I, Reul BA, Detry R and Brichard SM (1998) Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 83, 902-910.
9. Halleux CM, Declerck PJ, Tran SL, Detry R and Brichard SM (1999) Hormonal control of plasminogen activator inhibitor- 1 gene expression and production in human adipose tissue: Stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 84, 4097-4015.
10. Inoue S, Horii M, Asano T, Fujioka M, Ogura T and Shibatani M (2003) Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation. J Orthop Sci 8, 751-756.
11. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY and Séguin C (2006) Avascular necrosi of the femoral head: vascular hypotheses. Endothelium 13, 237-244.
12. Lara-Castro C, Fu Y, Chung BH and Garvey WT (2007) Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18, 263-270.
13. Mont MA, Jones LC and Hungerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88, 1117-1132.
14. Motomura G, Yamamoto T, Miyanishi K, Jingushi S and Iwamoto Y (2004) Combined effects of an anticoagulant anda lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 50, 3387-3391.
15. Nagasawa K, Tada Y, Koarada S, Tsukamoto H, Horiuchi T,Yoshizawa S and Murai K (2006) Prevention of steroidinduced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant. Lupus 15, 354-357.
16. Rodbell M (1964) Metabolism of isolated fat cell: I. Effects of hormones on glucose metabolism and lyplysis. J Biol Chem 239, 375-380.
17. Ronti T, Lupattelli G and Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol 64, 355-365.
18. Sugihara H,Yonemitsu N, Mitabara S and Yun K (1986) Primary culture of unicolor fat cells: characteristics of growth in vitro and change in differentiation properties. Differentiation31, 42-49.
19. Tan X, Cai D, Wu Y, Liu B, Rong L, Chen Z and Zhao Q 2006) Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. Transl Res 148, 114-119.
20. Wada M, Kumagai K, Murata M and Shindo H (2004) Warfarin reduces the incidence of osteonecrosis of the femoral head in spontaneously hypertensive rats. J Orthop Sci 9, 585-590.
21. Wang GJ and Cui Q (1997) The pathogenesis of steroidinduced osteonecrosis and the effect of lipid-clearing agents on this mechanism. In: Osteonecrosis. Etiology, Diagnosis, and Treatment (Urbaniak JR, Jones JP Jr, eds.), Rosemont, IL: American Academy of Orthopedic Surgeons 23, 159-165.
22. Zilberfarb V, Siquier K, Strosberg AD and Issad T (2001) Effect of dexamethasone on adipocyte differentiation markers and tumour necrosis factor-alpha expression in human PAZ6 cells. Diabetologia 44, 377-386.